» Articles » PMID: 35159699

Performance of Graphene/Polydimethylsiloxane Surfaces Against and Single- and Dual-Species Biofilms

Overview
Date 2022 Feb 15
PMID 35159699
Authors
Affiliations
Soon will be listed here.
Abstract

The increasing incidence of implant-associated infections has prompted the development of effective strategies to prevent biofilm formation on these devices. In this work, pristine graphene nanoplatelet/polydimethylsiloxane (GNP/PDMS) surfaces containing different GNP loadings (1, 2, 3, 4, and 5 wt%) were produced and evaluated on their ability to mitigate biofilm development. After GNP loading optimization, the most promising surface was tested against single- and dual-species biofilms of and . The antibiofilm activity of GNP/PDMS surfaces was determined by the quantification of total, viable, culturable, and viable but nonculturable (VBNC) cells, as well as by confocal laser scanning microscopy (CLSM). Results showed that 5 wt% GNP loading reduced the number of total (57%), viable (69%), culturable (55%), and VBNC cells (85%) of biofilms compared to PDMS. A decrease of 25% in total cells and about 52% in viable, culturable, and VBNC cells was observed for biofilms. Dual-species biofilms demonstrated higher resistance to the antimicrobial activity of GNP surfaces, with lower biofilm cell reductions (of up to 29% when compared to single-species biofilms). Still, the effectiveness of these surfaces in suppressing single- and dual-species biofilm formation was confirmed by CLSM analysis, where a decrease in biofilm biovolume (83% for biofilms and 42% for and dual-species biofilms) and thickness (on average 72%) was obtained. Overall, these results showed that pristine GNPs dispersed into the PDMS matrix were able to inhibit biofilm growth, being a starting point for the fabrication of novel surface coatings based on functionalized GNP/PDMS composites.

Citing Articles

Graphene-Based Composites for Biomedical Applications: Surface Modification for Enhanced Antimicrobial Activity and Biocompatibility.

Teixeira-Santos R, Belo S, Vieira R, Mergulhao F, Gomes L Biomolecules. 2023; 13(11).

PMID: 38002253 PMC: 10669141. DOI: 10.3390/biom13111571.


Exploring Nitrogen-Functionalized Graphene Composites for Urinary Catheter Applications.

Teixeira-Santos R, Gomes L, Vieira R, Sousa-Cardoso F, Soares O, Mergulhao F Nanomaterials (Basel). 2023; 13(18).

PMID: 37764632 PMC: 10536687. DOI: 10.3390/nano13182604.


Antibiofilm Potential of Coelomic Fluid and Paste of Earthworm (Clitellata, Megascolecidae) against Pathogenic Bacteria.

Hussain M, Liaqat I, Zafar U, Saleem S, Aftab M, Khalid A Microorganisms. 2023; 11(2).

PMID: 36838307 PMC: 9963238. DOI: 10.3390/microorganisms11020342.


Graphene-Based Coating to Mitigate Biofilm Development in Marine Environments.

Sousa-Cardoso F, Teixeira-Santos R, Campos A, Lima M, Gomes L, Soares O Nanomaterials (Basel). 2023; 13(3).

PMID: 36770342 PMC: 9919625. DOI: 10.3390/nano13030381.

References
1.
Wu X, Tan S, Xing Y, Pu Q, Wu M, Zhao J . Graphene oxide as an efficient antimicrobial nanomaterial for eradicating multi-drug resistant bacteria in vitro and in vivo. Colloids Surf B Biointerfaces. 2017; 157:1-9. DOI: 10.1016/j.colsurfb.2017.05.024. View

2.
Pandit S, Gaska K, Kadar R, Mijakovic I . Graphene-Based Antimicrobial Biomedical Surfaces. Chemphyschem. 2020; 22(3):250-263. PMC: 7898826. DOI: 10.1002/cphc.202000769. View

3.
Joung Y . Development of implantable medical devices: from an engineering perspective. Int Neurourol J. 2013; 17(3):98-106. PMC: 3797898. DOI: 10.5213/inj.2013.17.3.98. View

4.
Zhao M, Shan T, Wu Q, Gu L . The Antibacterial Effect of Graphene Oxide on . J Nanosci Nanotechnol. 2019; 20(4):2095-2103. DOI: 10.1166/jnn.2020.17319. View

5.
Seifi T, Kamali A . Anti-pathogenic activity of graphene nanomaterials: A review. Colloids Surf B Biointerfaces. 2020; 199:111509. DOI: 10.1016/j.colsurfb.2020.111509. View